Koichi Oshita

530 total citations
14 papers, 432 citations indexed

About

Koichi Oshita is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Koichi Oshita has authored 14 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Koichi Oshita's work include Mesenchymal stem cell research (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). Koichi Oshita is often cited by papers focused on Mesenchymal stem cell research (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). Koichi Oshita collaborates with scholars based in Japan. Koichi Oshita's co-authors include Yoshiya Tanaka, Kunihiro Yamaoka, Shunsuke Fukuyo, Yosuke Okada, Koshiro Sonomoto, Kazuhisa Nakano, Xiangmei Zhang, Kazuyoshi Saito, Kunio Sugahara and Kenji Chiba and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Koichi Oshita

14 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koichi Oshita Japan	9	227	132	112	97	70	14	432
Sharon Ansboro Ireland	8	149 0.7×	140 1.1×	195 1.7×	56 0.6×	63 0.9×	9	461
Guangyang Liu China	8	136 0.6×	257 1.9×	60 0.5×	97 1.0×	70 1.0×	23	416
Shawn A. Hallett United States	11	283 1.2×	108 0.8×	107 1.0×	35 0.4×	85 1.2×	16	506
Antonietta Fazio Italy	10	216 1.0×	139 1.1×	141 1.3×	35 0.4×	43 0.6×	23	458
Motokazu Tsuneto Japan	13	309 1.4×	75 0.6×	42 0.4×	138 1.4×	85 1.2×	37	530
Haizi Cheng United States	13	218 1.0×	59 0.4×	59 0.5×	57 0.6×	49 0.7×	25	444
Lilyanne C. Grevers Netherlands	8	269 1.2×	153 1.2×	292 2.6×	162 1.7×	56 0.8×	8	590
Runci Wang China	9	285 1.3×	98 0.7×	80 0.7×	211 2.2×	63 0.9×	15	538
Adel Ersek United Kingdom	8	242 1.1×	120 0.9×	34 0.3×	127 1.3×	102 1.5×	15	514
Bénédicte Brounais France	7	347 1.5×	110 0.8×	84 0.8×	182 1.9×	223 3.2×	11	714

Countries citing papers authored by Koichi Oshita

Since Specialization

Citations

This map shows the geographic impact of Koichi Oshita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Oshita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Oshita more than expected).

Fields of papers citing papers by Koichi Oshita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Oshita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Oshita. The network helps show where Koichi Oshita may publish in the future.

Co-authorship network of co-authors of Koichi Oshita

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Oshita. A scholar is included among the top collaborators of Koichi Oshita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Oshita. Koichi Oshita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Shimano, Kyoko, Yasuhiro Maeda, Hirotoshi Kataoka, et al.. (2019). Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4+CD45RBhigh T cells. PLoS ONE. 14(12). e0226154–e0226154. 29 indexed citations

Sugahara, Kunio, Yasuhiro Maeda, Kyoko Shimano, et al.. (2019). Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models. Journal of Immunology Research. 2019. 1–11. 18 indexed citations

Hikawa, Hidemasa, Seigo Ishibuchi, Naoki Sugiyama, et al.. (2016). A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor. Bioorganic & Medicinal Chemistry Letters. 26(5). 1365–1370. 8 indexed citations

Tanaka, Yoshiya, Koshiro Sonomoto, Masahiro Kondo, et al.. (2015). Mesenchymal stem cells for the treatment and repair of inflammatory arthritis. Japanese Journal of Clinical Immunology. 38(2). 86–92. 2 indexed citations

Fukuyo, Shunsuke, Kunihiro Yamaoka, Koshiro Sonomoto, et al.. (2014). IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Lara D. Veeken. 53(7). 1282–1290. 53 indexed citations

Kondo, Masahiro, Kunihiro Yamaoka, Koshiro Sonomoto, et al.. (2013). OP0307 Inhibitory Effects of IL-17 on Chondrogenic Differentiation of Human Mesenchymal Stem Cells Through the Phosphorylation of Sox9. Annals of the Rheumatic Diseases. 72. A158–A158. 1 indexed citations

Ishibuchi, Seigo, Koichi Oshita, Noriyasu Seki, et al.. (2013). A New Phenylpyrazoleanilide, Y-320, Inhibits Interleukin 17 Production and Ameliorates Collagen-Induced Arthritis in Mice and Cynomolgus Monkeys. Pharmaceuticals. 7(1). 1–17. 10 indexed citations

Kondo, Masahiro, Kunihiro Yamaoka, Koshiro Sonomoto, et al.. (2013). IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells. PLoS ONE. 8(11). e79463–e79463. 41 indexed citations

Oshita, Koichi, Kunihiro Yamaoka, & Yoshiya Tanaka. (2013). Regulation of Osteoclastogenesis by Human Mesenchymal Stem Cells Leading to Application of a Novel Treatment for Rheumatoid Arthritis. Journal of UOEH. 35(1). 33–37. 4 indexed citations

10.

Oshita, Koichi, Kunihiro Yamaoka, Masahiro Kondo, & Yoshiya Tanaka. (2013). Regulatory role of mesenchymal stem cells in osteoclast differentiation. Inflammation and Regeneration. 33(4). 217–222. 1 indexed citations

11.

Sonomoto, Koshiro, Kunihiro Yamaoka, Koichi Oshita, et al.. (2012). Interleukin‐1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt‐5a/receptor tyrosine kinase–like orphan receptor 2 pathway. Arthritis & Rheumatism. 64(10). 3355–3363. 131 indexed citations

12.

Oshita, Koichi, Kunihiro Yamaoka, Nobuyuki Udagawa, et al.. (2011). Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis & Rheumatism. 63(6). 1658–1667. 76 indexed citations

13.

Yamaoka, Kunihiro, Norifumi Sawamukai, Shohei Shimajiri, et al.. (2010). C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflammation Research. 59(8). 659–666. 44 indexed citations

14.

Kataoka, Hiroaki, M Ohtsuki, Kyoko Shimano, et al.. (2005). Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. Transplantation Proceedings. 37(1). 107–109. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact